Susquehanna International Group, LLP Minerva Neurosciences, Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$1.43 - $13.43 $286 - $2,686
-200 Reduced 1.14%
17,400 $27,000
Q3 2022

Nov 14, 2022
SELL
$2.53 - $13.17 $105,753 - $550,506
-41,800 Reduced 70.37%
17,600 $162,000
Q2 2022

Aug 15, 2022
BUY
$2.7 - $7.68 $160,380 - $456,192
59,400 New
59,400 $197,000

Others Institutions Holding NERV

# of Institutions
21
Shares Held
2.12M
Call Options Held
0
Put Options Held
0
View Full List

About Minerva Neurosciences, Inc.

NERV Quotes by TradingView
  • Ticker NERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,340,190
  • Market Cap $12.2M
  • Description
  • Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein ...
More about NERV
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email